Literature DB >> 28255107

A New Strategy for Transcatheter Left Atrial Appendage Closure With Cerebral Embolic Protection in Patient With Left Auricular Thrombosis and Total Contraindication to Long-Term Anticoagulation.

Salvatore Saccà, Jayme Ferro1, Tomoyuki Umemoto, Riccardo Turri, Carlo Penzo, Andrea Pacchioni.   

Abstract

Atrial fibrillation (AF) is the most common cardiac arrhythmia, occurring in 1%-2% of the general population. An important aspect is the treatment of AF in terms of stroke prevention. In patients with absolute contraindication to long-term anticoagulation due to high bleeding risk, a valuable alternative exists in left atrial appendage (LAA) closure. Unfortunately, thrombus in the LAA is a contraindication to the procedure because of high risk of embolization. We describe a clinical case with permanent AF, absolute contraindication to long-term anticoagulation therapy, and persistent thrombus formation in the LAA that was treated with transcatheter LAA closure and supraaortic trunk protection system in order to avoid risk of periprocedural stroke.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28255107

Source DB:  PubMed          Journal:  J Invasive Cardiol        ISSN: 1042-3931            Impact factor:   2.022


  1 in total

1.  Beating-heart Thoracoscopic Left Atrial Appendage Exclusion in a Patient with Left atrial Thrombus.

Authors:  Ali Khoynezhad
Journal:  J Atr Fibrillation       Date:  2017-12-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.